Cogstate Limited (ASX:CGS)

Cogstate Revenue

In the fiscal year ending June 30, 2026, Cogstate had annual revenue of $60.86M USD with 14.64% growth. Cogstate had revenue of $33.94M in the half year ending June 30, 2026, with 45.94% growth. That makes Cogstate the 26,369th largest company in the world by revenue and 464th in Australia.

• Revenue: $60.86M
• Revenue Growth: +14.64%
• P/S Ratio: 6.63
• Revenue / Employee: $380.40K
• Employees: 160
• Market Cap: 583.04M AUD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

Chart

• Clinical Trials (incl. Precision Recruitment Tool & Research) 58.37M 95.9%
• Healthcare (Incl. Sport) 2.50M 4.1%

Fiscal year ended Jun 30, 2026 See the full Cogstate breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	60.86M	7.77M	14.64%
Jun 30, 2025	53.09M	9.66M	22.25%
Jun 30, 2024	43.43M	2.98M	7.36%
Jun 30, 2023	40.45M	-4.53M	-10.07%
Jun 30, 2022	44.98M	12.28M	37.57%

Data Source: S&P Global Market Intelligence Last updated: Aug 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 28, 2026

Data Sources Report a data error